Casati Valter, Speziali Giovanni, D'Alessandro Cesare, Cianchi Clara, Antonietta Grasso Maria, Spagnolo Salvatore, Sandrelli Luca
Division of Cardiac Anesthesia and Intensive Care, and the Division of Cardiac Surgery, Policlinico di Monza, Monza, Italy.
Anesthesiology. 2002 Aug;97(2):367-73. doi: 10.1097/00000542-200208000-00013.
Recently, various studies have questioned the efficacy of intraoperative acute normovolemic hemodilution (ANH) in reducing bleeding and the need for allogeneic transfusions in cardiac surgery. The aim of the present study was to reevaluate the effects of a low-volume ANH in elective, adult open-heart surgery.
Two hundred four consecutive adult patients undergoing cardiac surgery were prospectively randomized in a nonblinded manner into two groups: ANH group (103 patients), where 5-8 ml/kg of blood was withdrawn before systemic heparinization and replaced with colloid solutions, and a control group, where no hemodilution was performed (101 patients). Procedures included single and multiple valve surgery, aortic root surgery, coronary surgery combined with valve surgery, or partial left ventriculectomy. The purpose of the study was to evaluate the efficacy of ANH in reducing the need for allogeneic blood components. Routine hematochemical evaluations, perioperative blood loss, major complications, and outcomes were also recorded.
No differences were found between the groups regarding demographics, baseline hematochemical data, and operative characteristics. There was no difference in the amount of transfusions of packed red cells, fresh frozen plasma, platelet concentrates, total number of patients transfused (control group, 36% vs. ANH group, 34.3%; P = 0.88), and amount of postoperative bleeding (control group, 412 ml [313-552 ml] vs. ANH group, 374 ml [255-704 ml]) (median [25th-75th percentiles]); P = 0.94. Further, perioperative complications, postoperative hematochemical data, and outcomes were not different.
In patients undergoing elective open-heart surgery, low-volume ANH showed lack of efficacy in reducing the need for allogeneic transfusions and postoperative bleeding.
最近,多项研究对术中急性等容血液稀释(ANH)在心脏手术中减少出血及异体输血需求的疗效提出质疑。本研究的目的是重新评估小容量ANH在择期成人心脏直视手术中的效果。
204例连续接受心脏手术的成年患者以前瞻性、非盲法随机分为两组:ANH组(103例患者),在全身肝素化前抽取5 - 8 ml/kg血液,并用胶体溶液替代;对照组(101例患者),不进行血液稀释。手术包括单瓣膜和多瓣膜手术、主动脉根部手术、冠状动脉手术联合瓣膜手术或部分左心室切除术。本研究的目的是评估ANH在减少异体血液成分需求方面的疗效。还记录了常规血液化学评估、围手术期失血量、主要并发症及结局。
两组在人口统计学、基线血液化学数据和手术特征方面无差异。在红细胞悬液、新鲜冰冻血浆、血小板浓缩物的输血量、输血患者总数(对照组36% vs. ANH组34.3%;P = 0.88)以及术后出血量(对照组412 ml [313 - 552 ml] vs. ANH组374 ml [255 - 704 ml])(中位数[第25 - 75百分位数])方面均无差异;P = 0.94。此外,围手术期并发症、术后血液化学数据及结局也无差异。
在接受择期心脏直视手术的患者中,小容量ANH在减少异体输血需求和术后出血方面显示无效。